Hideyuki Okano (left), dean of the Keio University Graduate School of Medicine, and Deepak Srivastava (right), Gladstone president, sign an agreement to increase research collaboration between the two organizations.
Gladstone Institutes recently signed an agreement to officially partner with the Keio University School of Medicine to increase cooperation and interaction. Keio University is among the top schools in Japan, with a distinguished track record in biomedical research.
The purpose of the agreement is to strengthen and promote research collaborations to further the scientific community’s collective understanding of stem cells, regenerative medicine, cardiovascular disease, neurodegenerative disease, and immunology.
Deepak Srivastava, MD, president of Gladstone, and Hideyuki Okano, MD, PhD, dean of the Keio University Graduate School of Medicine will meet yearly to discuss and explore new possible opportunities for future cooperation. Over the next 5 years, the partnership could include the exchange of research personnel, as well as the development of joint research projects and joint scientific publications.
The San Francisco Business Times has named Srivastava as one of the Most Admired CEOs among Bay Area businesses and nonprofits. The cardiologist and stem cell pioneer has served in the top leadership role at Gladstone Institutes since 2018.
Awards Institutional News News Release Congenital Heart Disease Cardiovascular Disease Srivastava LabCelebrating 25 years of neurological disease research at Gladstone
History Institutional News News Release Neurological DiseaseThis distinction recognizes his and the institute’s pioneering blend of genomics and immunology toward the design and improvement of cancer immunotherapy
Institutional News Genomic Immunology Marson Lab